204 related articles for article (PubMed ID: 15314162)
1. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2.
Liang M; Liang YY; Wrighton K; Ungermannova D; Wang XP; Brunicardi FC; Liu X; Feng XH; Lin X
Mol Cell Biol; 2004 Sep; 24(17):7524-37. PubMed ID: 15314162
[TBL] [Abstract][Full Text] [Related]
2. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Tokarz S; Berset C; La Rue J; Friedman K; Nakayama K; Nakayama K; Zhang DE; Lanker S
J Biol Chem; 2004 Nov; 279(45):46424-30. PubMed ID: 15342634
[TBL] [Abstract][Full Text] [Related]
3. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation.
Yang L; Wang N; Tang Y; Cao X; Wan M
Hum Mutat; 2006 Sep; 27(9):897-905. PubMed ID: 16865698
[TBL] [Abstract][Full Text] [Related]
4. SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.
Wan M; Huang J; Jhala NC; Tytler EM; Yang L; Vickers SM; Tang Y; Lu C; Wang N; Cao X
Am J Pathol; 2005 May; 166(5):1379-92. PubMed ID: 15855639
[TBL] [Abstract][Full Text] [Related]
5. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
Feng L; Guedes S; Wang T
J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
8. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.
Fukuchi M; Imamura T; Chiba T; Ebisawa T; Kawabata M; Tanaka K; Miyazono K
Mol Biol Cell; 2001 May; 12(5):1431-43. PubMed ID: 11359933
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
Chen G; Wang Y; Garate M; Zhou J; Li G
Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
[TBL] [Abstract][Full Text] [Related]
10. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
Lin X; Liang M; Feng XH
J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
Ohshima T; Shimotohno K
J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
[TBL] [Abstract][Full Text] [Related]
12. Differential ubiquitination defines the functional status of the tumor suppressor Smad4.
Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A
J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling.
Wang W; Ungermannova D; Jin J; Harper JW; Liu X
Oncogene; 2004 Feb; 23(5):1064-75. PubMed ID: 14676846
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-mediated degradation a mechanism for fine-tuning TGF-beta signaling.
Datto M; Wang XF
Cell; 2005 Apr; 121(1):2-4. PubMed ID: 15820671
[TBL] [Abstract][Full Text] [Related]
15. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.
Charrasse S; Carena I; Brondani V; Klempnauer KH; Ferrari S
Oncogene; 2000 Jun; 19(26):2986-95. PubMed ID: 10871850
[TBL] [Abstract][Full Text] [Related]
16. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
Huang Z; Nie L; Xu M; Sun XH
Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
Lo RS; Massagué J
Nat Cell Biol; 1999 Dec; 1(8):472-8. PubMed ID: 10587642
[TBL] [Abstract][Full Text] [Related]
18. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
[TBL] [Abstract][Full Text] [Related]
19. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
20. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL
Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]